Segui
Mario Angelico
Mario Angelico
Full Professor of Gastroenterology, Tor Vergata University
Email verificata su med.uniroma2.it
Titolo
Citata da
Citata da
Anno
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ...
Gastroenterology 150 (5), 1147-1159. e5, 2016
11042016
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
10422019
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ...
The Lancet 391 (10138), 2417-2429, 2018
4492018
Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids
AF Attili, M Angelico, A Cantafora, D Alvaro, L Capocaccia
Medical hypotheses 19 (1), 57-69, 1986
3441986
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis
M Angelico, D Di Paolo, MO Trinito, A Petrolati, A Araco, S Zazza, ...
Hepatology 35 (1), 176-181, 2002
2272002
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
V Mazzaferro, D Citterio, S Bhoori, M Bongini, R Miceli, L De Carlis, ...
The Lancet Oncology 21 (7), 947-956, 2020
2262020
Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis
M Angelico, L Carli, C Piat, S Gentile, L Capocaccia
Gastroenterology 113 (5), 1632-1639, 1997
2191997
Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis
M Angelico, L Carli, C Piat, S Gentile, V Rinaldi, E Bologna, L Capocaccia
Gastroenterology 104 (5), 1460-1465, 1993
1851993
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence
G Tisone, G Orlando, A Cardillo, G Palmieri, TM Manzia, L Baiocchi, ...
Journal of hepatology 44 (4), 702-709, 2006
1742006
Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections
M Angelico, E Renganathan, C Gandin, M Fathy, MC Profili, W Rafai, ...
Journal of hepatology 26 (2), 236-243, 1997
1711997
Relationships between bile salts hydrophilicity and phospholipid composition in rile of various animal species
DAA Cantafora, A Attili, SG Corradini, C De Luca, G Minervini, A DiBiase, ...
Comp. Biochem. Physiol 83 (3), 551-554, 1986
1681986
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha
G Alpini, L Baiocchi, S Glaser, Y Ueno, M Marzioni, H Francis, JL Phinizy, ...
Hepatology 35 (5), 1041-1052, 2002
1522002
A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
P Piccolo, I Lenci, L Demelia, F Bandiera, MR Piras, G Antonucci, ...
Antiviral therapy 14 (8), 1165-1174, 2009
1382009
Hepatobiliary complications associated with total parenteral nutrition
M Angelico, PD Guardia
Alimentary pharmacology & therapeutics 14, 54-57, 2000
1372000
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression
R Salpini, L Colagrossi, MC Bellocchi, M Surdo, C Becker, C Alteri, ...
Hepatology 61 (3), 823-833, 2015
1362015
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients
M Andreoni, D Goletti, P Pezzotti, A Pozzetto, P Monini, L Sarmati, ...
Journal of Infection 43 (3), 195-199, 2001
1312001
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry
F Violi, RG Corazza, SH Caldwell, F Perticone, A Gatta, M Angelico, ...
Internal and emergency medicine 11, 1059-1066, 2016
1282016
Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone …
N Figura, F Cetta, M Angelico, G Montalto, D Cetta, L Pacenti, C Vindigni, ...
Digestive diseases and sciences 43, 854-862, 1998
1181998
13C‐methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation
A Petrolati, D Festi, G De Berardinis, L Colaiocco‐Ferrante, D Di Paolo, ...
Alimentary pharmacology & therapeutics 18 (8), 785-790, 2003
1172003
Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience
A Orlacchio, G Bazzocchi, D Pastorelli, F Bolacchi, M Angelico, ...
Cardiovascular and interventional radiology 31, 587-594, 2008
1102008
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20